Two weeks ago, I wrote to tell you that, just halfway through the month of April, pot stock investors were benefitting from several powerful profit catalysts.
Any one of these would be great news for the sector, but there were three in play, all working to power weed stocks higher.
To be honest, things were looking so good, I didn't think the action could get much better...
But it sure did.
As if on cue, here in the last half of the month, some exciting, bullish new developments have come together to bring us even bigger gains.
U.S. Pot Stocks Are Set to Enjoy a Renewed "Trump Bump"
Now that California's mammoth $3.75 billion legal weed market is up and running, most of the cannabis cognoscenti have been watching Canada.
And for good reason.
This summer, Canada will become the first North American nation to fully legalize marijuana, even for recreational purposes. That's expected to add $5 billion in yearly sales to that nation's already big medical marijuana industry.
RELATED: Top five tiny Canadian pot stocks are set to skyrocket. Click here...
Even without recreational marijuana in Canada or California, North American legal marijuana sales soared 33% last year, to $9.7 billion. And marijuana research firm ArcView expects that trend to continue at a compound annual growth rate of 28% through 2021, when there could be $25 billion or more in North American sales.
But now, that attention is swinging back in America's direction.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.